Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IV Meloxicam for Pain Management Post TJA: Prospective Randomized Trial

NCT05291598 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT05291598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05291598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IV Meloxicam for Pain Management Post TJA: Prospective Randomized Trial
Lead sponsor
University of Miami
Phase
Phase 3
Overall status
Completed
Start date
May 1, 2022
Completion date
May 1, 2023
Enrollment
223 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

total hip replacement, total knee replacement